The role of actin-binding proteins in the control of endothelial barrier integrity

Thrombosis and Haemostasis

Volumn 113, Issue 1, 2015, Pages 20-36

  García Ponce, Alexander ^a   Citalán Madrid, Alí Francisco ^a   Velázquez Avila, Martha ^a   Vargas Robles, Hilda ^a   Schnoor, Michael ^a  

^a Department of Physiology Biophysics and Neurosciences Center for Research and Advanced Studies of the National Polytechnic Institute (Cinvestav IPN)   (Mexico)

Author keywords

Actin cytoskeleton; Cell cell interactions; Endothelial cells; GTPases; Inflammation; Vascular permeability

Indexed keywords

ACTIN BINDING PROTEIN; ACTIN CAPPING PROTEIN; ACTIN RELATED PROTEIN 2-3 COMPLEX; CARRIER PROTEINS AND BINDING PROTEINS; COFILIN 1; CORTACTIN; DREBRIN; EPITHELIAL CELL ADHESION MOLECULE; EZRIN; FILAMIN; FORMIN HOMOLOGY DOMAIN PROTEIN 1; G ACTIN; GELSOLIN; GUANOSINE TRIPHOSPHATASE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 90; LIPOPOLYSACCHARIDE; MDIA1; MOESIN; MYOSIN; MYOSIN ADENOSINE TRIPHOSPHATASE; NUCLEATION PROMOTING FACTOR; PROTEIN CAPZ; RADIXIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASODILATOR STIMULATED PHOSPHOPROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN;

BLOOD FLOW; BLOOD VESSEL PERMEABILITY; CROSS LINKING; CYTOSKELETON; DEPOLYMERIZATION; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; MEMBRANE STRUCTURE; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMERISATION; REGULATORY MECHANISM; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; TIGHT JUNCTION; VASCULARIZATION; WOUND HEALING; ACTIN FILAMENT; ANIMAL; CAPILLARY PERMEABILITY; CELL JUNCTION; METABOLISM;

ACTIN CYTOSKELETON; ACTOMYOSIN; ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR JUNCTIONS; MICROFILAMENT PROTEINS; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84922362173     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-04-0298     Document Type: Review

References (146)

1. Goddard LM, et al. Cellular and molecular regulation of vascular permeability. Thromb Haemost 2013; 109: 407-415.
2. Giannotta M, et al. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Develop Cell 2013; 26: 441-454.
3. Luissint AC, et al. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS 2012; 9: 23.
4. Leick M, et al. Leukocyte recruitment in inflammation: basic concepts and new mechanistic insights based on new models and microscopic imaging technologies. Cell Tissue Res 2014; Epub ahead of print.
5. Chavez A, et al. New insights into the regulation of vascular permeability. Intern Rev Cell Mol Biol 2011; 290: 205-248.
6. Ward PA. New approaches to the study of sepsis. EMBO Mol Med 2012; 4: 1234-1243.
7. Eltzschig HK, Eckle T. Ischaemia and reperfusion--from mechanism to translation. Nature Med 2011; 17: 1391-1401.
8. Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res 2009; 77: 53-63.
9. Oldenburg J, de Rooij J. Mechanical control of the endothelial barrier. Cell Tissue Res 2014; Epub ahead of print.
10. Spindler V, et al. Role of GTPases in control of microvascular permeability. Cardiovasc Res 2010; 87: 243-253.
11. Hansen MD, Kwiatkowski AV. Control of actin dynamics by allosteric regulation of actin binding proteins. Intern Rev Cell Mol Biol 2013; 303: 1-25.
12. Rottner K, Stradal TE. Actin dynamics and turnover in cell motility. Curr Opin Cell Biol 2011; 23: 569-578.
13. Firat-Karalar EN, Welch MD. New mechanisms and functions of actin nucleation. Curr Opin Cell Biol 2011; 23: 4-13.
14. Rotty JD, et al. New insights into the regulation and cellular functions of the ARP2/3 complex. Nature Rev Mol Cell Biol 2013; 14: 7-12.
15. LeClaire LL, 3rd, et al. Phosphorylation of the Arp2/3 complex is necessary to nucleate actin filaments. J Cell Biol 2008; 182: 647-654.
16. Pollard TD. Regulation of actin filament assembly by Arp2/3 complex and formins. Ann Rev Biophys Biomol Struct 2007; 36: 451-477.
17. MacGrath SM, Koleske AJ. Cortactin in cell migration and cancer at a glance. J Cell Sci 2012; 125: 1621-1626.
18. Oelkers JM, Vinzenz M, Nemethova M, et al. Microtubules as platforms for assaying actin polymerisation in vivo. PLoS One 2011; 6: e19931.
19. Pollitt AY, Insall RH. WASP and SCAR/WAVE proteins: the drivers of actin assembly. J Cell Sci 2009; 122: 2575-2578.
20. Kim AS, et al. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 2000; 404: 151-158.
21. Ardern H, et al. Src-dependent phosphorylation of Scar1 promotes its association with the Arp2/3 complex. Cell Motility Cytoskeleton 2006; 63: 6-13.
22. Campellone KG, Welch MD. A nucleator arms race: cellular control of actin assembly. Nature Rev Mol Cell Biol 2010; 11: 237-251.
23. Yang C, et al. Novel roles of formin mDia2 in lamellipodia and filopodia formation in motile cells. PLoS Biol 2007; 5: e317.
24. Takeya R, et al. The mammalian formin FHOD1 is activated through phosphorylation by ROCK and mediates thrombin-induced stress fibre formation in endothelial cells. EMBO J 2008; 27: 618-628.
25. Ryu JR, Echarri A, Li R, et al. Regulation of cell-cell adhesion by Abi/Diaphanous complexes. Mol Cell Biol 2009; 29: 1735-1748.
26. Bugyi B, Carlier MF. Control of actin filament treadmilling in cell motility. Ann Rev Biophys 2010; 39: 449-470.
27. Vavylonis D, et al. Model of formin-associated actin filament elongation. Mol Cell 2006; 21: 455-466.
28. Poukkula M, et al. Actin-depolymerizing factor homology domain: a conserved fold performing diverse roles in cytoskeletal dynamics. Cytoskeleton 2011; 68: 471-490.
29. Bravo-Cordero JJ, et al. Functions of cofilin in cell locomotion and invasion. Nature Rev Mol Cell Biol 2013; 14: 405-415.
30. Aoki C, et al. Drebrin A is a postsynaptic protein that localizes in vivo to the submembranous surface of dendritic sites forming excitatory synapses. J Comp Neurol 2005; 483: 383-402.
31. Peitsch WK, et al. Drebrin is a widespread actin-associating protein enriched at junctional plaques, defining a specific microfilament anchorage system in polar epithelial cells. Eur J Cell Biol 1999; 78: 767-778.
32. Menna E, et al. From filopodia to synapses: the role of actin-capping and anticapping proteins. Eur J Neurosci 2011; 34: 1655-1662.
33. Akin O, Mullins RD. Capping protein increases the rate of actin-based motility by promoting filament nucleation by the Arp2/3 complex. Cell 2008; 133: 841-851.
34. Stevenson RP, et al. Actin-bundling proteins in cancer progression at a glance. J Cell Sci 2012; 125: 1073-1079.
35. Mendes Pinto I, et al. Force to divide: structural and mechanical requirements for actomyosin ring contraction. Biophys J 2013; 105: 547-554.
36. Prochniewicz E, et al. Myosin isoform determines the conformational dynamics and cooperativity of actin filaments in the strongly bound actomyosin complex. J Mol Biol 2010; 396: 501-509.
37. Lin JJ, et al. Chapter 1: roles of caldesmon in cell motility and actin cytoskeleton remodelling. Intern Rev Cell Mol Biol 2009; 274: 1-68.
38. Shen Q, et al. Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc Res 2010; 87: 272-280.
39. Huveneers S, de Rooij J. Mechanosensitive systems at the cadherin-F-actin interface. J Cell Sci 2013; 126: 403-413.
40. Yonemura S, et al. alpha-Catenin as a tension transducer that induces adherens junction development. Nature Cell Biol 2010; 12: 533-542.
41. Birukova AA, et al. Afadin controls p120-catenin-ZO-1 interactions leading to endothelial barrier enhancement by oxidized phospholipids. J Cell Physiol 2012; 227: 1883-1890.
42. Bazzoni G. Endothelial tight junctions: permeable barriers of the vessel wall. Thromb Haemost 2006; 95: 36-42.
43. Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 2008; 1778: 660-669.
44. Gonzalez-Mariscal L, et al. ZO proteins and redox-dependent processes. Antioxid Redox Signal 2011; 15: 1235-1253.
45. Blum MS, et al. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am J Physiol 1997; 273: H286-294.
46. Stamatovic SM, et al. Potential role of MCP-1 in endothelial cell tight junction ’opening’: signalling via Rho and Rho kinase. J Cell Sci 2003; 116: 4615-4628.
47. Yao Y, Tsirka SE. Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption. J Cell Sci 2011; 124: 1486-1495.
48. Alluri H, Stagg HW, Wilson RL, et al. Reactive oxygen species-caspase-3 relationship in mediating blood-brain barrier endothelial cell hyperpermeability following oxygen-glucose deprivation and reoxygenation. Microcirculation 2014; 21: 187-195.
49. Lin YL, et al. Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J Nutrition 2010; 140: 2187-2192.
50. Carmeliet P, et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999; 98: 147-157.
51. Dejana E, Vestweber D. The role of VE-cadherin in vascular morphogenesis and permeability control. Prog Mol Biol Transl Sci 2013; 116: 119-144.
52. Schulte D, Kuppers V, Dartsch N, et al. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J 2011; 30: 4157-4170.
53. Blecharz KG, et al. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells. J Cerebral Blood Flow Metabol 2008; 28: 1139-1149.
54. Oas RG, et al. p120-catenin and beta-catenin differentially regulate cadherin adhesive function. Mol Biol Cell 2013; 24: 704-714.
55. Chiasson CM, et al. p120-catenin inhibits VE-cadherin internalisation through a Rho-independent mechanism. Mol Biol Cell 2009; 20: 1970-1980.
56. Rajput C, et al. Neural Wiskott-Aldrich syndrome protein (N-WASP)-mediated p120-catenin interaction with Arp2-Actin complex stabilizes endothelial adherens junctions. J Biol Chem 2013; 288: 4241-4250.
57. Lee YH, et al. Transforming growth factor-beta1 effects on endothelial monolayer permeability involve focal adhesion kinase/Src. Am J Respir Cell Mol Biol 2007; 37: 485-493.
58. Arnold KM, et al. Loss of focal adhesion kinase enhances endothelial barrier function and increases focal adhesions. Microcirculation 2013; 20: 637-649.
59. Abu Taha A, et al. ARP2/3-mediated junction-associated lamellipodia control VE-cadherin-based cell junction dynamics and maintain monolayer integrity. Mol Biol Cell 2014; 25: 245-256.
60. Humphries JD, et al. Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol 2007; 179: 1043-1057.
61. Mierke CT, et al. Mechano-coupling and regulation of contractility by the vinculin tail domain. Biophys J 2008; 94: 661-670.
62. Huveneers S, et al. Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodelling. J Cell Biol 2012; 196: 641-652.
63. Millan J, et al. Adherens junctions connect stress fibres between adjacent endothelial cells. BMC Biol 2010; 8: 11.
64. Chervin-Petinot A, et al. Epithelial protein lost in neoplasm (EPLIN) interacts with alpha-catenin and actin filaments in endothelial cells and stabilizes vascular capillary network in vitro. J Biol Chem 2012; 287: 7556-7572.
65. Maul RS, et al. EPLIN regulates actin dynamics by cross-linking and stabilizing filaments. J Cell Biol 2003; 160: 399-407.
66. Tawa H, et al. Role of afadin in vascular endothelial growth factor-and sphingosine 1-phosphate-induced angiogenesis. Circ Res 2010; 106: 1731-1742.
67. Ramirez SH, et al. Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J Cerebral Blood Flow Metabol 2009; 29: 1933-1945.
68. Martins T, Burgoyne T, Kenny BA, et al. Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells. Neuropharmacol 2013; 65: 74-82.
69. Park M, et al. Methamphetamine-induced occludin endocytosis is mediated by the Arp2/3 complex-regulated actin rearrangement. J Biol Chem 2013; 288: 33324-33334.
70. Gavard J, et al. Angiopoietin-1 Prevents VEGF-Induced Endothelial Permeability by Sequestering Src through mDia. Developm Cell 2008; 14: 25-36.
71. Watanabe N, et al. Cooperation between mDia1 and ROCK in Rho-induced actin reorganisation. Nature Cell Biol 1999; 1: 136-143.
72. Liu Z, et al. Mechanical tugging force regulates the size of cell-cell junctions. Proc Natl Acad Sci USA 2010; 107: 9944-9949.
73. Shen Q, et al. Endothelial contractile cytoskeleton and microvascular permeability. Cell Health Cytoskelet 2009; 2009: 43-50.
74. Chislock EM, Pendergast AM. Abl family kinases regulate endothelial barrier function in vitro and in mice. PLoS One 2013; 8: e85231.
75. Dudek SM, et al. Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. Mol Biol Cell 2010; 21: 4042-4056.
76. Srinivas SP, et al. Histamine-induced phosphorylation of the regulatory light chain of myosin II disrupts the barrier integrity of corneal endothelial cells. Invest Ophthalmol Visual Sci 2006; 47: 4011-4018.
77. Aslam M, et al. Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase. J Physiol 2013; 591: 461-473.
78. Jia Z, et al. Phytoestrogen genistein protects against endothelial barrier dysfunction in vascular endothelial cells through PKA-mediated suppression of RhoA signalling. Endocrinology 2013; 154: 727-737.
79. Ando K, et al. Rap1 potentiates endothelial cell junctions by spatially controlling myosin II activity and actin organisation. J Cell Biol 2013; 202: 901-916.
80. Post A, et al. Rasip1 mediates Rap1 regulation of Rho in endothelial barrier function through ArhGAP29. Proc Natl Acad Sci USA 2013; 110: 11427-11432.
81. Wilson CW, et al. Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signalling. Blood 2013; 122: 3678-3690.
82. Citalán-Madrid A, et al. Small GTPases of the Ras superfamily regulate intestinal epithelial homeostasis and barrier function via common and unique mechanisms. Tissue Barriers 2013; 1: e26938.
83. Beckers CM, et al. Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost 2010; 103: 40-55.
84. Duluc L, Wojciak-Stothard B. Rho GTPases in the regulation of pulmonary vascular barrier function. Cell Tissue Res 2014; 355: 675-685.
85. Borbiev T, et al. p38 MAP kinase-dependent regulation of endothelial cell permeability. Am J Physiol Lung Cell Mol Physiol 2004; 287: L911-918.
86. Chu ZG, et al. p38 MAP kinase mediates burn serum-induced endothelial barrier dysfunction: involvement of F-actin rearrangement and L-caldesmon phosphorylation. Shock 2010; 34: 222-228.
87. Birukov KG, et al. Shear stress-mediated cytoskeletal remodelling and cortactin translocation in pulmonary endothelial cells. Am J Respir Cell Mol Biol 2002; 26: 453-464.
88. Dudek SM, et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem 2004; 279: 24692-24700.
89. Brown M, et al. Quantitative distribution and colocalisation of non-muscle myosin light chain kinase isoforms and cortactin in human lung endothelium. Microvasc Res 2010; 80: 75-88.
90. Adamson RH, et al. Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. Cardiovasc Res 2010; 88: 344-351.
91. Schnoor M, et al. Cortactin deficiency is associated with reduced neutrophil recruitment but increased vascular permeability in vivo. J Exp Med 2011; 208: 1721-1735.
92. Yang L, et al. Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodelling during polymorphonuclear leukocyte adhesion and transmigration. J Immunol 2006; 177: 6440-6449.
93. van Buul JD, et al. RhoG regulates endothelial apical cup assembly downstream from ICAM1 engagement and is involved in leukocyte trans-endothelial migration. J Cell Biol 2007; 178: 1279-1293.
94. Koss M, et al. Ezrin/radixin/moesin proteins are phosphorylated by TNF-alpha and modulate permeability increases in human pulmonary microvascular endothelial cells. J Immunol 2006; 176: 1218-1227.
95. Bogatcheva NV, et al. Ezrin, radixin, and moesin are phosphorylated in response to 2-methoxyestradiol and modulate endothelial hyperpermeability. Am J Respir Cell Mol Biol 2011; 45: 1185-1194.
96. Adyshev DM, et al. Ezrin/radixin/moesin proteins differentially regulate endothelial hyperpermeability after thrombin. Am J Physiol Lung Cell Mol Physiol 2013; 305: L240-255.
97. Adyshev DM, et al. Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement. Cell Signal 2011; 23: 2086-2096.
98. Guo X, et al. ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability. Am J Physiol Heart Circ Physiol 2009; 297: H238-246.
99. Wang J, et al. RhoA/ROCK-dependent moesin phosphorylation regulates AGEinduced endothelial cellular response. Cardiovasc Diabetol 2012; 11: 7.
100. Bear JE, Gertler FB. Ena/VASP: towards resolving a pointed controversy at the barbed end. J Cell Sci 2009; 122: 1947-1953.
101. Comerford KM, et al. Role of vasodilator-stimulated phosphoprotein in PKAinduced changes in endothelial junctional permeability. FASEB J 2002; 16: 583-585.
102. Schlegel N, Burger S, Golenhofen N, et al. The role of VASP in regulation of cAMP-and Rac 1-mediated endothelial barrier stabilisation. Am J Physiol Cell Physiol 2008; 294: C178-188.
103. Schlegel N, Waschke J. VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells. Am J Physiol Cell Physiol 2009; 296: C453-462.
104. Rentsendorj O, et al. Role of vasodilator-stimulated phosphoprotein in cGMPmediated protection of human pulmonary artery endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 2008; 294: L686-697.
105. Furman C, et al. Ena/VASP is required for endothelial barrier function in vivo. J Cell Biol 2007; 179: 761-775.
106. Benz PM, et al. Cytoskeleton assembly at endothelial cell-cell contacts is regulated by alphaII-spectrin-VASP complexes. J Cell Biol 2008; 180: 205-219.
107. Schlegel N, Waschke J. Impaired integrin-mediated adhesion contributes to reduced barrier properties in VASP-deficient microvascular endothelium. J Cell Physiol 2009; 220: 357-366.
108. Profirovic J, et al. Vasodilator-stimulated phosphoprotein deficiency potentiates PAR-1-induced increase in endothelial permeability in mouse lungs. J Cell Physiol 2011; 226: 1255-1264.
109. Rosenberger P, et al. Identification of vasodilator-stimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia. FASEB J 2007; 21: 2613-2621.
110. Schmit MA, et al. Vasodilator phosphostimulated protein (VASP) protects endothelial barrier function during hypoxia. Inflammation 2012; 35: 566-573.
111. Henes J, et al. Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury. FASEB J 2009; 23: 4244-4255.
112. Davis B, et al. Role of vasodilator stimulated phosphoprotein in VEGF induced blood-brain barrier permeability in endothelial cell monolayers. Intern J Develop Neurosci 2010; 28: 423-428.
113. Nieset JE, et al. Characterisation of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin. J Cell Sci 1997; 110: 1013-1022.
114. Singleton PA, et al. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J 2005; 19: 1646-1656.
115. Quadri SK, et al. Cadherin selectivity filter regulates endothelial sieving properties. Nature Commun 2012; 3: 1099.
116. Nowak KJ, Davies KE. Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep 2004; 5: 872-876.
117. Nico B, et al. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice. Glia 2003; 42: 235-251.
118. Palladino M, et al. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler Thromb Vasc Biol 2013; 33: 2867-2876.
119. Ding Z, et al. Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis. J Cell Sci 2006; 119: 4127-4137.
120. Li Z, et al. The role of profilin-1 in endothelial cell injury induced by advanced glycation end products (AGEs). Cardiovasc Diabetol 2013; 12: 141.
121. Nakamura F, et al. The filamins: organizers of cell structure and function. Cell Adhes Migration 2011; 5: 160-169.
122. Griffiths GS, et al. R-Ras interacts with filamin a to maintain endothelial barrier function. J Cell Physiol 2011; 226: 2287-2296.
123. Bogatcheva NV, et al. Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability. J Cell Physiol 2009; 221: 750-759.
124. Su YT, et al. Monoubiquitination of filamin B regulates vascular endothelial growth factor-mediated trafficking of histone deacetylase 7. Mol Cell Biol 2013; 33: 1546-1560.
125. Slee JB, Lowe-Krentz LJ. Actin realignment and cofilin regulation are essential for barrier integrity during shear stress. J Cell Biochem 2013; 114: 782-795.
126. Mikati MA, et al. Drebrin-induced stabilisation of actin filaments. J Biol Chem 2013; 288: 19926-19938.
127. 127.Worth DC, et al. Drebrin contains a cryptic F-actin-bundling activity regulated by Cdk5 phosphorylation. J Cell Biol 2013; 202: 793-806.
128. Peitsch WK, et al. Drebrin, an actin-binding, cell-type characteristic protein: induction and localisation in epithelial skin tumors and cultured keratinocytes. J Invest Dermatol 2005; 125: 761-774.
129. Rehm K, et al. Drebrin preserves endothelial integrity by stabilizing nectin at adherens junctions. J Cell Sci 2013; 126: 3756-3769.
130. Nag S, et al. Gelsolin: the tail of a molecular gymnast. Cytoskeleton 2013; 70: 360-384.
131. Endres M, et al. Neuroprotective effects of gelsolin during murine stroke. J Clin Invest 1999; 103: 347-354.
132. Becker PM, et al. Pulmonary vascular permeability and ischaemic injury in gelsolin-deficient mice. Am J Respir Cell Mol Biol 2003; 28: 478-484.
133. Lind SE, et al. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J Clin Invest 1986; 78: 736-742.
134. Bucki R, et al. Plasma gelsolin modulates cellular response to sphingosine 1-phosphate. Am J Physiol Cell Physiol 2010; 299: C1516-1523.
135. Barginear MF, et al. The heat shock protein 90 chaperone complex: an evolving therapeutic target. Curr Cancer Drug Targets 2008; 8: 522-532.
136. Chatterjee A, et al. Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis. Am J Resp Crit Care Med 2007; 176: 667-675.
137. Antonov A, et al. Heat shock protein 90 inhibitors protect and restore pulmonary endothelial barrier function. Am J Respir Cell Mol Biol 2008; 39: 551-559.
138. Chatterjee A, et al. Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. Am J Physiol Lung Cell Mol Physiol 2008; 294: L755-763.
139. Antonov AS, et al. Regulation of endothelial barrier function by TGF-beta type I receptor ALK5: potential role of contractile mechanisms and heat shock protein 90. J Cell Physiol 2012; 227: 759-771.
140. Liu T, et al. Modulation of HSP27 alters hypoxia-induced endothelial permeability and related signalling pathways. J Cell Physiol 2009; 220: 600-610.
141. Carman CV. Mechanisms for transcellular diapedesis: probing and pathfinding by ’invadosome-like protrusions’. J Cell Sci 2009; 122: 3025-3035.
142. Martinelli R, et al. Release of cellular tension signals self-restorative ventral lamellipodia to heal barrier micro-wounds. J Cell Biol 2013; 201: 449-465.
143. Maddugoda MP, et al. cAMP signalling by anthrax edema toxin induces transendothelial cell tunnels, which are resealed by MIM via Arp2/3-driven actin polymerisation. Cell Host Microbe 2011; 10: 464-474.
144. Jones CA, et al. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nature Med 2008; 14: 448-453.
145. Cheng Y, et al. Effect of Robo4 on retinal endothelial permeability. Curr Eye Res 2013; 38: 128-136.
146. Sheldon H, et al. Active involvement of Robo1 and Robo4 in filopodia formation and endothelial cell motility mediated via WASP and other actin nucleation-promoting factors. FASEB J 2009; 23: 513-522.